He Jie Tang in the treatment of chronic hepatitis B patients

Table 4 T lymphocyte subsets in responders and non-responders of group I before and after the treatment (mean±SD)

		n	CD3 (%)	CD4 (%)	CD8 (%)	NK (%)
Responders	Pre-T	7	66.02±8.86	35.10±4.76b	34.92±4.36b	43.52±7.1b
	Post-T	7	67.80±9.11	38.85±8.85a	30.15±5.82a	55.60±8.2a
Non-responders	Pre-T	43	65.50±9.08	34.92±6.30b	34.77±6.56b	42.93±6.7 b
	Post-T	43	66.09±9.35	35.99±8.70	34.25±5.52	45.60±6.5
Group III		20	68.10±9.25	39.27±8.70	30.96±6.82	59.65±7.5

^aP<0.05 vs before treatment in the same group;

^bP<0.01 vs group III.